Helmut Zodl - Feb 1, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role: Chief Financial Officer
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol: GEHC
Transactions as of: Feb 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/3/2023, 05:03 PM
Previous filing: Jan 5, 2023
Next filing: Dec 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GEHC	Common Stock, par value $0.01 per share	Award	$0	+5.36K	+12.48%	$0.00	48.3K	Feb 1, 2023	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GEHC	Employee Stock Option (right to buy)	Award		+47K			47K	Feb 1, 2023	Common Stock, par value $0.01 per share	47K	$70.01	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.
F2	Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3	The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 5,356 newly awarded restricted stock units and 42,919 previously reported restricted stock units.
F4	Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.